Are Currently Selected Laboratory Animals Useful in the Research of How Female Hormones Influence Orthodontic Biomechanics?
Małgorzata PerugaBeata KawalaMichal SarulJakub KotowiczJoanna LisPublished in: Animals : an open access journal from MDPI (2023)
Animal testing was and remains the only method of introducing a certain treatment and medical procedure on humans. On the other hand, animals have their rights resulting from applicable legal acts, including Directive 2010/63/EU and, indirectly, the World Medical Association International Code of Medical Ethics (Helsinki Declaration, 1975, amended 2000). Thus, the question arises whether the credibility of the results of hormonal and orthodontic tests obtained so far and their usefulness for the human population is scientifically justified and worth sacrificing laboratory animals for. Especially that, according to statistical data, about 50% of laboratory animals are euthanized at the conclusion of the experiments. The aim of this article was to determine whether animal experiments are scientifically or morally justified in bringing significant evidence in studies that may validate the influence of changes in the concentration of female hormones secreted by the ovaries in various phases of the menstrual cycle in young patients on the duration of an increased tooth movement rate in orthodontic treatment. Papers reporting the results of the original research into female hormones, either natural or exogeneous ones, likely to alternate the orthodontic tooth movement rate were critically evaluated in terms of animal selection. Thorough analysis supported by veterinary knowledge proved that none of the publications enabled an extrapolation of the results to humans. The evaluation of the relation between the rate of tooth movement upon loading with orthodontic forces and hormones either secreted during the menstrual cycle of women or released from the contraceptives already present in the market, does not require sacrificing laboratory animals.
Keyphrases
- healthcare
- oral health
- end stage renal disease
- polycystic ovary syndrome
- newly diagnosed
- ejection fraction
- chronic kidney disease
- public health
- emergency department
- type diabetes
- minimally invasive
- pregnant women
- prognostic factors
- electronic health record
- patient reported outcomes
- machine learning
- adverse drug
- induced pluripotent stem cells
- risk assessment
- data analysis
- pluripotent stem cells
- metabolic syndrome
- patient reported
- cervical cancer screening